Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus

Clinical and Epidemiological Characteristics and Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus Under Routine Clinical Practice

The purpose of the study is to get data of prevalence of testosterone deficiency in patient with T2DM in Russian Federation

Clinical and Epidemiological Characteristics and Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus Under Routine Clinical Practice (DESTINY)

Inclusion Criteria:

• Male 45-60 years old
• Diagnosis of T2DM according to approved standards
• Signed Informed Consent Form

Exclusion Criteria:

• Prepubertal hypogonadism of any genesis;
• Sexual and developmental disorders;
• Absence of at least one of the testicles;
• Cryptorchidism, including in the anamnesis;
• Injuries and / or surgical interventions on the genitals with loss of at least one of the testicles;
• Established diagnosis of panhypopituitarism in accordance with current recommendations / standards;
• Androgen therapy, administered at the time of the study or in the anamnesis;
• Admission of anabolic steroids;
• Alcoholism or drug addiction;
• Insolvency.